Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company, 49929 [2018-21543]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 192 / Wednesday, October 3, 2018 / Notices
indirectly acquire American Bank of
Commerce, both of Provo, Utah.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Board of Governors of the Federal Reserve
System, September 28, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2018–21544 Filed 10–2–18; 8:45 am]
FEDERAL RESERVE SYSTEM
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than October
15, 2018.
A. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Breck C. Collingsworth, Lincoln,
Nebraska, individually and as part of a
group acting in concert with Susan
Chrastil, Crete, Nebraska; to acquire
voting shares of TCM Company, Crete,
Nebraska, and thereby indirectly acquire
shares of City Bank & Trust Co., Lincoln,
Nebraska.
Board of Governors of the Federal Reserve
System, September 28, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
daltland on DSKBBV9HB2PROD with NOTICES
BILLING CODE 6210–01–P
VerDate Sep<11>2014
18:05 Oct 02, 2018
Jkt 247001
[Docket No. CDC–2018–0091]
Proposed Revised Vaccine Information
Materials for Meningococcal ACWY
and DTaP (Diphtheria, Tetanus,
Pertussis) Vaccines
BILLING CODE 6210–01–P
[FR Doc. 2018–21543 Filed 10–2–18; 8:45 am]
Centers for Disease Control and
Prevention
Under the National
Childhood Vaccine Injury Act (NCVIA),
the Centers for Disease Control and
Prevention (CDC) within the
Department of Health and Human
Services (HHS) develops vaccine
information materials that all health
care providers are required to give to
patients/parents prior to administration
of specific vaccines. HHS/CDC seeks
written comment on the proposed
updated vaccine information statements
for meningococcal ACWY and DTaP
(diphtheria, tetanus, acellular pertussis)
vaccines.
DATES: Written comments must be
received on or before December 3, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0091, by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Written comments should be
addressed to Suzanne Johnson-DeLeon
(VISComments@cdc.gov), National
Center for Immunization and
Respiratory Diseases, Centers for
Disease Control and Prevention,
Mailstop A–19, 1600 Clifton Road NE,
Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
docket number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Skip
Wolfe, National Center for
Immunization and Respiratory Diseases,
Centers for Disease Control and
Prevention, Mailstop A–19, 1600 Clifton
Road NE, Atlanta, Georgia 30329;
VISComments@cdc.gov.
SUPPLEMENTARY INFORMATION: The
National Childhood Vaccine Injury Act
of 1986 (Pub. L. 99–660), as amended by
section 708 of Public Law 103–183,
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
49929
added section 2126 to the Public Health
Service Act. Section 2126, codified at 42
U.S.C. 300aa–26, requires the Secretary
of Health and Human Services to
develop and disseminate vaccine
information materials for distribution by
all health care providers in the United
States to any patient (or to the patient’s
parent or legal representative in the case
the patient is a child) receiving vaccines
covered under the National Vaccine
Injury Compensation Program (VICP).
Development and revision of the
vaccine information materials, also
known as Vaccine Information
Statements (VIS), have been delegated
by the Secretary to the Centers for
Disease Control and Prevention (CDC).
Section 2126 requires that the materials
be developed, or revised, after notice to
the public, with a 60-day comment
period, and in consultation with the
Advisory Commission on Childhood
Vaccines, appropriate health care
provider and parent organizations, and
the Food and Drug Administration. The
law also requires that the information
contained in the materials be based on
available data and information, be
presented in understandable terms, and
include:
(1) A concise description of the
benefits of the vaccine,
(2) A concise description of the risks
associated with the vaccine,
(3) A statement of the availability of
the National Vaccine Injury
Compensation Program, and
(4) Such other relevant information as
may be determined by the Secretary.
The vaccines initially covered under
the National Vaccine Injury
Compensation Program were diphtheria,
tetanus, pertussis, measles, mumps,
rubella and poliomyelitis vaccines.
Since April 15, 1992, any health care
provider in the United States who
intends to administer one of these
covered vaccines is required to provide
copies of the relevant vaccine
information materials prior to
administration of any of these vaccines.
Since then, the following vaccines have
been added to the National Vaccine
Injury Compensation Program, requiring
provision of vaccine information
materials before vaccine administration
for them as well: hepatitis B,
Haemophilus influenzae type b (Hib),
varicella (chickenpox), pneumococcal
conjugate, rotavirus, hepatitis A,
meningococcal, human papillomavirus
(HPV), and seasonal influenza vaccines.
Instructions for use of the vaccine
information materials are found on the
CDC website at: https://www.cdc.gov/
vaccines/hcp/vis/.
CDC is proposing updated versions of
the meningococcal ACWY and DTaP
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 83, Number 192 (Wednesday, October 3, 2018)]
[Notices]
[Page 49929]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21543]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices; Acquisitions of Shares of a Bank
or Bank Holding Company
The notificants listed below have applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and Sec. 225.41 of the Board's
Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank
holding company. The factors that are considered in acting on the
notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
The notices are available for immediate inspection at the Federal
Reserve Bank indicated. The notices also will be available for
inspection at the offices of the Board of Governors. Interested persons
may express their views in writing to the Reserve Bank indicated for
that notice or to the offices of the Board of Governors. Comments must
be received not later than October 15, 2018.
A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant
Vice President) 1 Memorial Drive, Kansas City, Missouri 64198-0001:
1. Breck C. Collingsworth, Lincoln, Nebraska, individually and as
part of a group acting in concert with Susan Chrastil, Crete, Nebraska;
to acquire voting shares of TCM Company, Crete, Nebraska, and thereby
indirectly acquire shares of City Bank & Trust Co., Lincoln, Nebraska.
Board of Governors of the Federal Reserve System, September 28,
2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2018-21543 Filed 10-2-18; 8:45 am]
BILLING CODE 6210-01-P
